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Abstract
Epidemiology studies are an essential part of clinical research,
often forming the foundation for studies ranked more highly in the
hierarchy of evidence-based medicine. Studies of sepsis to date
have been conducted on local, regional, national and international
scales, with the majority conducted in the past 5 years.
Longitudinal epidemiology studies convey an important additional
aspect of the healthcare burden from disease, and may additionally
serve to compare the effectiveness and efficiency of healthcare
systems, to examine specific patient care strategies and to perform
quality control analyses.
Value of epidemiology studies in critical care
Epidemiology studies are often overlooked in the current
world of evidence-based medicine. The studies do not rank in
the hierarchy of clinical trial data, they are not often
considered to influence clinical care and they may be
considered merely ‘descriptive’ of a medical problem. Despite
the limitations of epidemiology studies, they remain a critical
component of biomedical research without which the
remaining ‘higher order’ studies, such as cohort studies and
controlled trials, could not be effectively conducted.
Critical care epidemiology studies, of which the current study
from the Intensive Care National Audit and Research Center
database is a good example [1], serve a variety of purposes
that advance the mission of both practicing intensive care
unit (ICU) physicians and scientific researchers. At the most
basic level, epidemiology studies convey important
information about disease characteristics, the type of patients
affected, and the frequency and outcomes of the disease.
Importantly, these studies keep medical events in
perspective. Epidemiology studies report and reinforce the
frequency of deaths related to atherosclerotic disease,
cancer and sepsis in developed countries, and of deaths from
a variety of infectious diseases and sepsis in developing
countries. These reminders are essential in an era of
increasing media attention on diseases such as severe acute
respiratory syndrome and avian influenza that are less
immediate public health concerns.
Descriptive epidemiology studies also inform intensivists
about the type of conditions they should expect to encounter
in their ICU (i.e. the frequency of disease) and they guide
clinicians in treating patients by reporting information on
relative causality (such as Streptococcus pneumoniae being
the most common cause of community-acquired pneumonia).
Local and regional epidemiology data have long been
disseminated to tailor therapy for infectious diseases based
on local organism resistance patterns. In contrast, larger
epidemiology studies are invaluable for determining
healthcare resource allocation and for the design and
conduct of both observational and interventional clinical trials.
Value of longitudinal epidemiology studies
Longitudinal studies add a vitally important characteristic to
point-prevalence or time-limited epidemiology studies. They
permit characterization of temporal changes in affected
patients and in disease characteristics, such as in the
frequency, complications and outcomes of a disease.
Longitudinal studies also permit more detailed planning for
healthcare resource allocation, in particular by matching
temporal changes in disease or disease-specific outcomes
with known changes in underlying patient populations (e.g.
HIV-positive) or according to rendered treatments (e.g.
antibiotics, chemotherapeutics). Longitudinal epidemiology
studies on a local level can be utilized for quality control
purposes, to assess the impact of changes in healthcare
delivery. In general, longitudinal studies are invaluable for
understanding how a disease is changing and how it affects
patients in the studied healthcare system.
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Institutional, regional, national and
international epidemiology studies
Epidemiology studies that cross physical and geopolitical
borders permit broader comparisons than would be possible
for observations that are geographically constrained. Most
simply, they allow comparisons to be drawn for diseases
according to different pressures, such as differing underlying
patient populations and different risk factors for disease.
More broadly, when epidemiology studies are conducted they
longitudinally create the ability to examine healthcare quality
and effectiveness of resource utilization on a regional scale or
a national scale in relation to scientific advances. Data of this
kind are essential for determining the optimal ICU utilization
for a given condition, tracking the effectiveness and efficiency
of healthcare systems according to changes in disease
incidence or outcome, and for planning research studies
according to the characteristics of the disease.
Large-scale longitudinal studies in sepsis
In the present issue of Critical Care, investigators from the
Intensive Care National Audit and Research Center report the
results of a longitudinal study of severe sepsis encompassing
England, Wales and Northern Ireland in the past 10 years [1].
These data are indispensable as a baseline assessment for a
common and lethal condition in the respective countries,
where severe sepsis occupies more than one-quarter of ICU
beds and carries fatality rates approaching 50%. The data
confirm previous secular trends in the incidence and mortality
of sepsis [2-4] and define the severity of disease and
heterogeneity of case-mix typical of sepsis. With these data in
hand, scientists and healthcare administrators may assess
the impact of community interventions designed to reduce
the incidence of sepsis or medical therapies that may improve
outcomes with sepsis.
The value of these data is even more apparent in a system of
national healthcare insurance, where tracking of health-related
outcomes related to resource allocation is necessary to ensure
appropriate healthcare delivery. Other large-scale epidemiology
studies exist for sepsis, either by sampling locally, [5] regionally
[3,6-9], nationally [4,10-15] or internationally [16,17]. Few
available studies cross systems of care or permit direct
comparisons of healthcare delivery strategies. Those studies
that include longitudinal data provide important additional
insights into sepsis epidemiology while minimizing seasonal
influences. Continued investigation is necessary to optimize
healthcare quality and to compare the effectiveness and
efficiency of different ICU utilization and care strategies, both
nationally and internationally.
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